PKM and renal cell carcinoma: For instance, elevated levels of ROS inhibit pyruvate kinase 2 (PKM2, the final key enzyme in aerobic glycolysis) acetylation to avoid its lysosomal-dependent degradation, thus weakening the sensitivity of renal cell carcinoma (RCC) to doxorubicin [10].